BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21503694)

  • 1. Treatment of cutaneous lupus.
    Chang AY; Werth VP
    Curr Rheumatol Rep; 2011 Aug; 13(4):300-7. PubMed ID: 21503694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
    Nutan F; Ortega-Loayza AG
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.
    Hejazi EZ; Werth VP
    Am J Clin Dermatol; 2016 Apr; 17(2):135-46. PubMed ID: 26872954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lupus erythematosus: update of therapeutic options part II.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e195-213. PubMed ID: 20800319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different faces of cutaneous lupus erythematosus.
    Renner R; Sticherling M
    G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lupus erythematosus: update of therapeutic options part I.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e179-93. PubMed ID: 20739095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic treatment of cutaneous lupus erythematosus].
    Wenzel J; Bieber T; Uerlich M; Tüting T
    J Dtsch Dermatol Ges; 2003 Sep; 1(9):694-704. PubMed ID: 16285276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin manifestations in lupus erythematosus: clinical aspects and therapy].
    Kuhn A; Ruland V; Bonsmann G
    Z Rheumatol; 2011 Apr; 70(3):213-26; quiz 227. PubMed ID: 21494937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cutaneous manifestations of lupus erythematosus: A systematic review.
    Fairley JL; Oon S; Saracino AM; Nikpour M
    Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of "refractory" skin disease in patients with lupus erythematosus.
    Callen JP
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
    Rosen JD; Paul S; Maderal A
    Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cutaneous lupus erythematosus: current practice variations.
    Reich A; Werth VP; Furukawa F; Kuhn A; Szczęch J; Samotij D; Szepietowski JC
    Lupus; 2016 Aug; 25(9):964-72. PubMed ID: 26821963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous lupus erythematosus. Part 2: diagnostics and therapy].
    Kuhn A; Gensch K; Ständer S; Bonsmann G
    Hautarzt; 2006 Apr; 57(4):345-8; quiz 359. PubMed ID: 16547761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG; Kouvelas D
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus.
    Sigges J; Biazar C; Landmann A; Ruland V; Patsinakidis N; Amler S; Bonsmann G; Kuhn A;
    Autoimmun Rev; 2013 May; 12(7):694-702. PubMed ID: 23220353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic approach and treatment of cutaneous lupus erythematosus.
    Sticherling M; Bonsmann G; Kuhn A
    J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
    J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lupus erythematosus: diagnosis and management.
    Fabbri P; Cardinali C; Giomi B; Caproni M
    Am J Clin Dermatol; 2003; 4(7):449-65. PubMed ID: 12814335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.